These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 7647834)

  • 1. An open-label study of nefazodone in the treatment of depression with and without comorbid obsessive compulsive disorder.
    Nelson EC
    Ann Clin Psychiatry; 1994 Dec; 6(4):249-53. PubMed ID: 7647834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The tridimensional personality questionnaire as a predictor of response to nefazodone treatment of depression.
    Nelson EC; Cloninger CR
    J Affect Disord; 1995 Oct; 35(1-2):51-7. PubMed ID: 8557887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reemergence of sexual dysfunction in patients with major depressive disorder: double-blind comparison of nefazodone and sertraline.
    Ferguson JM; Shrivastava RK; Stahl SM; Hartford JT; Borian F; Ieni J; McQuade RD; Jody D
    J Clin Psychiatry; 2001 Jan; 62(1):24-9. PubMed ID: 11235924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nefazodone and imipramine in major depression: a placebo-controlled trial.
    Rickels K; Schweizer E; Clary C; Fox I; Weise C
    Br J Psychiatry; 1994 Jun; 164(6):802-5. PubMed ID: 7952987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An open-label trial of nefazodone in high comorbidity panic disorder.
    DeMartinis NA; Schweizer E; Rickels K
    J Clin Psychiatry; 1996 Jun; 57(6):245-8. PubMed ID: 8666561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Controlled comparison of nefazodone and amitriptyline in major depressive inpatients.
    Ansseau M; Darimont P; Lecoq A; De Nayer A; Evrard JL; Krémer P; Devoitille JM; Dierick M; Mertens C; Mesotten F
    Psychopharmacology (Berl); 1994 Jun; 115(1-2):254-60. PubMed ID: 7862904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of comorbid obsessive-compulsive and depressive disorders in children age].
    Goriunov AV; Lobacheva MV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(11 Pt 2):48-52. PubMed ID: 23257756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The association between obsessive compulsive disorder and obsessive compulsive personality disorder: prevalence and clinical presentation.
    Gordon OM; Salkovskis PM; Oldfield VB; Carter N
    Br J Clin Psychol; 2013 Sep; 52(3):300-15. PubMed ID: 23865406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nefazodone for chronic daily headache prophylaxis: an open-label study.
    Saper JR; Lake AE; Tepper SJ
    Headache; 2001 May; 41(5):465-74. PubMed ID: 11380644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A double-blind, placebo-controlled trial of nefazodone in the treatment of patients hospitalized for major depression.
    Feighner J; Targum SD; Bennett ME; Roberts DL; Kensler TT; D'Amico MF; Hardy SA
    J Clin Psychiatry; 1998 May; 59(5):246-53. PubMed ID: 9632036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of nefazodone on comorbid anxiety symptoms associated with depression: experience in family practice and psychiatric outpatient settings.
    Zajecka JM
    J Clin Psychiatry; 1996; 57 Suppl 2():10-4. PubMed ID: 8626357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Obsessive compulsive disorder, depression, and fluoxetine.
    Hollander E; Mullen L; DeCaria CM; Skodol A; Schneier FR; Liebowitz MR; Klein DF
    J Clin Psychiatry; 1991 Oct; 52(10):418-22. PubMed ID: 1938978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-dose escitalopram for the treatment of obsessive-compulsive disorder.
    Rabinowitz I; Baruch Y; Barak Y
    Int Clin Psychopharmacol; 2008 Jan; 23(1):49-53. PubMed ID: 18090508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluvoxamine treatment of obsessive-compulsive disorder.
    Perse TL; Greist JH; Jefferson JW; Rosenfeld R; Dar R
    Am J Psychiatry; 1987 Dec; 144(12):1543-8. PubMed ID: 3120604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A double-blind, placebo-controlled trial of two dose ranges of nefazodone in the treatment of depressed outpatients.
    Mendels J; Reimherr F; Marcus RN; Roberts DL; Francis RJ; Anton SF
    J Clin Psychiatry; 1995; 56 Suppl 6():30-6. PubMed ID: 7649971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aripiprazole in schizophrenia patients with comorbid obsessive-compulsive symptoms: an open-label study of 15 patients.
    Glick ID; Poyurovsky M; Ivanova O; Koran LM
    J Clin Psychiatry; 2008 Dec; 69(12):1856-9. PubMed ID: 19026264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Symptomatic and syndromal anxiety in chronic forms of major depression: effect of nefazodone, cognitive behavioral analysis system of psychotherapy, and their combination.
    Ninan PT; Rush AJ; Crits-Christoph P; Kornstein SG; Manber R; Thase ME; Trivedi MH; Rothbaum BO; Zajecka J; Borian FE; Keller MB
    J Clin Psychiatry; 2002 May; 63(5):434-41. PubMed ID: 12025827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Open trial of nefazodone for combat-related posttraumatic stress disorder.
    Hertzberg MA; Feldman ME; Beckham JC; Moore SD; Davidson JR
    J Clin Psychiatry; 1998 Sep; 59(9):460-4. PubMed ID: 9771816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of obsessive symptoms during nefazodone treatment.
    Sofuoglu M; Debattista C
    Am J Psychiatry; 1996 Apr; 153(4):577-8. PubMed ID: 8599413
    [No Abstract]   [Full Text] [Related]  

  • 20. Nefazodone in the treatment of elderly patients with depressive disorders: a prospective, observational study.
    Saiz-Ruiz J; Ibañez A; Díaz-Marsá M; Arias F; Carrasco JL; Huertas D; Martín-Carrasco M; Moreno I; Rico-Villademoros F
    CNS Drugs; 2002; 16(9):635-43. PubMed ID: 12153334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.